Background Inhaled nitric oxide (iNO) is effective in term infants with hypoxic respiratory
failure. The pathophysiology of respiratory failure and the potential risks of iNO differ …

Background Nitric oxide (NO) is a major endogenous regulator of vascular tone. Inhaled nitric
oxide (iNO) gas has been investigated as treatment for persistent pulmonary hypertension …

This guideline was developed by the Canadian CDH Collaborative, a panel of specialists
from across Canada with expertise in the fields of maternal-fetal medicine, pediatric surgery, …

OBJECTIVE: To compare breathing patterns and lung function in the supine, lateral, and prone
positions in oxygen-dependent preterm infants. STUDY DESIGN: Respiratory function in …

The main cause of pulmonary hypertension in newborn babies results from the failure of the
pulmonary circulation to dilate at birth, termed ‘persistent pulmonary hypertension of the …

This guideline was developed by the Canadian CDH Collaborative, a panel of specialists
from across Canada with expertise in the fields of maternal-fetal medicine, pediatric surgery, …

OBJECTIVE: To determine the hemodynamic impact of fluid restriction in preterm newborns
with significant patent ductus arteriosus. STUDY DESIGN: Newborns ≥24 and <32 weeks’ …

Background: Helping trainees develop appropriate clinical reasoning abilities is a challenging
goal in an environment where clinical situations are marked by high levels of complexity …

Background Fluid restriction is often recommended as part of the management of infants with
early or established bronchopulmonary dysplasia (BPD). Objectives To determine whether …

METHODS: Clinicians from different backgrounds participated in a standardized, videotaped,
simulated neonatal resuscitation in the presence of parent actors. The infant remained …